Point-of-care Ultrasound in Finland

NCT03327688 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 220

Last updated 2021-09-05

No results posted yet for this study

Summary

This study has two aims.

1. Deep venous thrombosis (DVT) is a common suspected medical condition. If it cannot be excluded clinically and using D-dimer, ultrasound examination is required. An option for traditional radiologist-performed ultrasound is a 2-point compression ultrasound (2-CUS). The safety of this technique is proven. However there does not exist any data on costs comparing traditional and 2-CUS pathways in primary health care. This study will evaluate the total cost of both pathways by conducting a cost-minimization analysis. It will also study the effect of a simple ultrasound education on the referrals to hospital due to suspected DVT.

Hypothesis 1: Short education in ultrasound will reduce significantly referrals to hospital and save resources.
2. Length of stay (LOS) in emergency department (ED) is related to increased mortality, morbidity, prolonged hospital stay and probably patient satisfaction. LOS of patients with a point-of-care ultrasound (POCUS) performed by an emergency physician (EP) will be compared to those that have a radiology performed ultrasound examination. Further examination and accuracy of POCUS will be noted.

Hypothesis 2: POCUS can shorten LOS significantly in selected clinical conditions

Conditions

  • Deep Vein Thrombosis
  • Abdominal Aortic Aneurism
  • Pneumothorax
  • Gallbladder Diseases
  • Hydronephrosis
  • Pregnancy, Ectopic
  • Ascites
  • Pleural Effusion
  • Pericardial Effusion

Interventions

DIAGNOSTIC_TEST

Point-of-care ultrasound

Point-of-care ultrasound performed by an emergency physician

Sponsors & Collaborators

  • University of Eastern Finland

    collaborator OTHER
  • Ossi Hannula

    lead OTHER

Principal Investigators

  • Harri Hyppölä, docent · Kuopio University Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-20
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03327688 on ClinicalTrials.gov